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Agmatine, at concentrations of 10 μM or 100 μM, is able to induce oxidative stress in rat liver mitochondria (RLM), as evidenced by increased
oxygen uptake, H2O2 generation, and oxidation of sulfhydryl groups and glutathione. One proposal for the production of H2O2 and, most
probably, other reactive oxygen species (ROS), is that they are the reaction products of agmatine oxidation by an unknown mitochondrial amine
oxidase. Alternatively, by interacting with an iron–sulfur center of the respiratory chain, agmatine can produce an imino radical and subsequently
the superoxide anion and other ROS. The observed oxidative stress causes a drop in ATP synthesis and amplification of the mitochondrial
permeability transition (MPT) induced by Ca2+. Instead, 1 mM agmatine generates larger amounts of H2O2 than the lower concentrations, but does
not affect RLM respiration or redox levels of thiols and glutathione. Indeed, it maintains the normal level of ATP synthesis and prevents Ca2+-
induced MPT in the presence of phosphate. The self-scavenging effect against ROS production by agmatine at higher concentrations is also
proposed.
© 2007 Elsevier B.V. All rights reserved.Keywords: Agmatine; Mitochondria; Reactive oxygen species; Permeability transition1. Introduction
Agmatine, an amine dication at physiological pH, is formed
by decarboxylation of L-arginine catalyzed by the enzyme
arginine decarboxylase (ADC). Although agmatine and ADC
have been recognized since early in the last century in plants,
bacteria and invertebrates, for many years they were not
believed to be synthesized in mammals. Only in 1994 were
agmatine and ADC discovered in rat and bovine brain [1] and
subsequently in many other mammalian organs and cell types
[2]. It is known that agmatine binds to α2-adrenergic andAbbreviations: ADC, arginine decarboxylase; AGM, agmatine; BHT,
butylhydroxytoluene; CsA, cyclosporin A; DMO, 5,5′-dimethyl-oxazolidine-
2,4-dione; MAO, monoamine oxidase; MPT, mitochondrial permeability
transition; NEM, N-ethylmaleimide; NOS, nitric oxide synthase; RLM, rat
liver mitochondria; ROS, reactive oxygen species; TPP+, tetraphenylpho-
sphonium; ΔΨ, membrane potential
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doi:10.1016/j.bbamem.2007.01.011imidazoline receptors and exhibits neurotransmitter or neuro-
modulator properties (for a review, see Ref. [3]). Several other
effects on metabolism have also been demonstrated. Agmatine
acts as a competitive inhibitor of nitric oxide synthase (NOS)
[4] and induces ornithine decarboxylase antizyme [5] and
spermidine/spermine acetyl transferase [6]. In fact, in all species
agmatine is metabolized by agmatinase to urea and putrescine
[7], suggesting that it is a polyamine precursor. In mammals,
agmatine is not only synthesized “in situ” by ADC but is also
taken up by exogenous sources and transported to several
organs, in particular the liver, by an energy-dependent
mechanism [8]. It has been reported that, in rat hepatocytes,
increased agmatine concentration, by provoking polyamine
depletion, promotes apoptosis by increasing caspase-3 activity.
This occurs through mitochondrial swelling and release of
cytochrome c [9]. Agmatine has also been found in neuronal
mitochondria [10], and its metabolic enzymes, ADC and
agmatinase, have also been recognized in mitochondria [11–
13], as well as the imidazoline receptor, I2, which binds
agmatine although its function is still unknown [14]. Very
Fig. 1. Effect of agmatine on oxygen consumption (A) and membrane potential
(B) of RLM. RLM were incubated in standard medium, as described in
Materials and methods. Agmatine (AGM) concentrations are indicated at side of
traces. Panel A: when present, NEM and BHT were 10 μM and 25 μM,
respectively. Panel B: 2 μM TPP+ was present for ΔΨ measurements. ΔE:
electrode potential. Inset: effect of 1 mM agmatine on ΔpH. RLM were
incubated in standard medium in presence of 400 μM [14C]DMO (1 μCi/mmol),
5 mM [3H]glycerol (100 μCi/mmol). Five additional experiments exhibited the
same trend.
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liver mitochondria by an energy-dependent mechanism,
exhibiting strict electrophoretic behavior and requiring high
membrane potential (ΔΨ) in order to operate [15].
The transport of agmatine in RLM accounts for its up-
regulation in ureagenesis, demonstrated in perfused liver [16],
coupled with stimulation of β-oxidation [17]. Indeed,
agmatine is also able to prevent dysfunction of Complex I in
renal cortex mitochondria [18], most probably by phosphor-
ylating the AQDQ subunit of the complex [19]. It has been
proposed that these findings may have important implications
for the prevention of mitochondrial diseases related to faulty
Complex I [18].
All these observations, revealing close relationships between
this amine and mitochondria, taken together with previous
reports on interactions among biogenic amines and mitochon-
dria, particularly at the level of oxygen consumption and ATP
synthesis [20,21] and MPT (for a review, see Ref. [22]), led us
to study the effect of agmatine on the bioenergetic function of
mitochondria and the role of this amine on MPT—more
specifically, on the induction of oxidative stress which, in this
regard, plays a fundamental role.
2. Materials and methods
2.1. Mitochondrial preparations
RLM were isolated by conventional differential centrifugation in a standard
medium containing 250 mM sucrose, 5 mM HEPES (pH 7.4) and 1 mM
EGTA; EGTA was omitted from the final washing solution. Protein content
was measured by the biuret method with bovine serum albumin as standard
[23].
2.2. Standard incubation procedures
RLM (1 mg protein/ml) were incubated in a water-jacketed cell at 20 °C. The
standard medium contained 200 mM sucrose, 10 mM HEPES (pH 7.4), 5 mM
succinate and 1.25 μM rotenone. Variations and/or other additions are described
with individual experiments presented.
2.3. Determination of mitochondrial functions
Δψ was calculated on the basis of distribution of the lipid-soluble cation
tetraphenylphosphonium (TPP+) through the inner membrane, measured by a
TPP+-specific electrode prepared in our laboratory according to published
procedures [24].
ΔpH was calculated from the distribution of [14C]DMO across the inner
membrane [25].
Mitochondrial matrix volume was calculated from the distribution of either
[14C]sucrose and 3H2O [26] or [
14C]sucrose and [3H]glycerol [27].
Mitochondrial swelling was determined by measuring the apparent
absorbance change of mitochondrial suspensions at 540 nm, on a Kontron
Uvikon mod. 922 spectrophotometer equipped with thermostatic control.
The protein sulfhydryl group oxidation assay was performed as in Ref. [28].
Oxidation of glutathione was performed as in Ref. [29].
The production of H2O2 in RLM was measured fluorometrically by the
scopoletin method [30] in an Aminco-Bowman 4-8202 spectrofluorometer.
Oxygen uptake was measured by a Clark electrode (Yellow Spring
Instruments, OH) in a closed vessel equipped with thermostatic control and
magnetic stirrer.
The redox state of endogenous pyridine nucleotides was directly followed
fluorometrically in an Aminco-Bowman 4-8202 spectrofluorometer, with
excitation at 354 nm and emission at 462 nm.3. Results
Fig. 1A shows that agmatine, at concentrations of 10 μM,
100 μM or 1 mM, definitely increases the rate of oxygen
consumption by RLM, incubated in standard medium, as
described in Materials and methods. In the presence of the
alkylating N-ethylmaleimide (NEM) or the antioxidant butyl-
hydroxytoluene (BHT), the increase in respiration by agmatine
is completely abolished (Fig. 1A). Note that ΔΨ is not affected
at the lower agmatine concentrations, whereas the higher one
induces a gradual decrease, as the result of its transport in the
inner compartment (see Ref. [15]) (Fig. 1B). The increase in the
58ΔpH value, which parallels the drop in ΔΨ upon addition of
1 mM agmatine (Fig. 1B, inset), demonstrates that RLM
maintain their energized state.
The observation that the extra oxygen uptake induced by all
amine concentrations is completely prevented by NEM or
BHT suggests that it is due to generation of ROS. In this
regard, Fig. 2 demonstrates that incubation of RLM in the
presence of agmatine results in a dose-dependent increase in
the generation of H2O2, thus confirming the above hypothesis.
The production of ROS by RLM generally leads to oxidative
stress, which particularly affects the redox levels of sulfhydryl
groups, glutathione, and the NAD(P)+/NAD(P)H pool. As Fig.
3A shows, 10 μM or 100 μM agmatine provokes decreases in
the content of reduced thiol groups by about 22% and 18%,
Fig. 2. Dose-dependent effect of agmatine on hydrogen peroxide production in
RLM. Incubation conditions and agmatine concentrations as in Fig. 1. Mean
values±SD of five experiments are reported.
Fig. 3. Effect of agmatine on redox state of mitochondrial sulfhydryl groups (A),
glutathione (B) and pyridine nucleotides (C). RLMwere incubated for 20 min in
standard medium, as described in Materials and methods. Agmatine concentra-
tions are indicated. 10 μM NEM, 25 μM BHT and 50 μM clorgyline were
present where indicated. Results of histograms A and B are mean values of four
experiments±SD. Statistical analysis on panels A and B was carried out with
Student's t-test (+p<0.05 vs. control). Panel C shows a typical experiment; three
others gave identical results.
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ineffective. It is noteworthy that NEM or BHT completely
prevent the lowering of reduced thiol levels by 10 μM
agmatine, whereas the MAO inhibitor, clorgyline, is comple-
tely ineffective. Similar observations are obtained in reduced
glutathione, as agmatine induces oxidation of about 35% and
27% at 10 μM or 100 μM concentrations, respectively. NEM or
BHT fully prevents it, and clorgyline is still ineffective. Also in
this case, 1 mM agmatine does not show any effect (Fig. 3B).
Instead, when compared with controls, the results of Fig. 3C do
not show any appreciable increase by agmatine, at any
concentration, in the oxidation of pyridine nucleotides.
One first important implication regarding the effect of
agmatine at low concentrations (10 or 100 μM) on RLM is
shown in Fig. 4. Agmatine strongly reduces the RCI and ADP/
O ratio of RLM, indicating that it affects ATP biosynthesis.
Instead, also in this case, 1 mM agmatine maintains
phosphorylation parameters near normal levels.
Another important effect of agmatine, which may have
physio-pathological implications on cells, is shown in Fig. 5.
When suspended in standard medium, in the presence of
supraphysiological Ca2+ concentrations, RLM undergo the
phenomenon of MPT (for a review, see Ref. [31]). The MPT is
revealed by mitochondrial swelling, detectable by a decrease in
the apparent absorbance at 540 nm of the suspension induced by
Ca2+ (Fig. 5). Agmatine at 10 μM or 100 μM further amplifies
absorbance decrease (10 μM is slightly more effective), which
is completely abolished by the MPT inhibitor cyclosporin A
(CsA); at 1 mM agmatine concentration, the phenomenon is
completely inhibited.
The opening of the transition pore by Ca2+ (Fig. 5) is closely
related to the oxidation of thiols (about 15%) induced by the
cation (Fig. 6A). Its amplification by 10 μM agmatine (Fig. 5)
provokes an increase in thiol oxidation (about 25%) (Fig. 6A)
when compared with that of Ca2+ or agmatine alone, as shown
in Fig. 3A. Instead, 1 mM agmatine maintains thiol redox levels
like those of controls. Glutathione oxidation during pore
opening shows an almost identical trend to that for sulfhydrylgroups (Fig. 6B). In these conditions, 10 μM agmatine is also
able to induce strong oxidation of pyridine nucleotides (Fig.
6C), which are released out of mitochondria together with
glutathione, adenine nucleotides, endogenous cations, etc. This
release is paralleled by a large accumulation of sucrose, which is
responsible for the observed colloid osmotic swelling (results
not reported). Also in this case, 1 mM agmatine is still
ineffective (Fig. 6C). It should be emphasized that 1 mM
agmatine can also prevent oxidative stress and the MPT induced
by other ROS producers (results not reported).
Note that results obtained at low agmatine concentrations (10
or 100 μM) sometimes give rise to large fluctuations in the
extent of MPT induction. Our present results demonstrate the
significant effect of agmatine (see Fig. 5), but some preparations
Fig. 4. Effect of agmatine on respiratory control index (RCI) and ADP/O ratio. RLM were incubated in standard medium, as in Fig. 1, in 1 mM phosphate. Agmatine
concentrations are indicated in table listing RCI and ADP/O values. 200 μM ADP was added where indicated. Three other experiments gave superimposable curves.
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explained by the fact that RLM preparations occasionally
contain microperoxysomes as contaminants. In these cases,
peroxysomal catalase can destroy much of the H2O2 produced
by agmatine, which rapidly diffuses out of the mitochondrion,
thus preventing this ROS (or its derivatives) from inducing
oxidative stress.
All the above experiments were performed in a sucrose-
based medium in order to exploit the same conditions used to
study agmatine transport in RLM [15] and to compare results on
MPT with those reported in the literature (see, e.g. [32,33]).
However, KCl-based medium gave similar results.
4. Discussion
The results reported here show that, at low concentrations
(10 or 100 μM), agmatine can induce oxidative stress in RLM,Fig. 5. Effect of agmatine on mitochondrial swelling induced by Ca2+ in
presence of phosphate. RLMwere incubated in standard medium in 30 μMCa2+
and 1 mM phosphate, where present 1 μM CsA. Agmatine concentrations are
indicated on side of curves. Control: no Ca2+. Five other experiments gave
superimposable curves. Note that, if extent of absorbance decrease in presence
of Ca2+ alone is too large, effects of 10 and 100 μM agmatine can no longer be
observed.as evidenced by the generation of H2O2 (Fig. 2), resulting in
increased oxygen uptake (Fig. 1A) and oxidation of thiol
groups and glutathione (Fig. 3A, B) of the same extent
previously observed with other pro-oxidants [32,33]. It should
be noted that increased oxygen consumption by agmatine,
associated with the regulation of urea synthesis, has previously
been observed in perfused liver [16]. This oxidation, however,
does not damage the mitochondrial membrane, as ΔΨ remains
at normal levels (Fig. 1B). The above concentrations are
considered low, as the concentration of agmatine in hepatocyte
cytosol is 0.5 mM [9]. Also, the amounts of hydrogen peroxide
detected in our experimental conditions cannot be considered
for rigorous quantitative evaluation, as the measured H2O2 was
that which diffused out of the mitochondria. Indeed, it should
also be noted that H2O2, as soon it forms inside the
mitochondria, may be transformed into other ROS, e.g., the
potent oxidant hydroxyl radical, by the Fenton reaction. The
mechanism by which agmatine produces H2O2 (or other ROS)
as a result of its interaction with RLM is not yet known. One
possibility is that, on entering the mitochondrial matrix,
agmatine is oxidized by an amine oxidase producing H2O2
and guanidobutyric aldehyde. Monoamine oxidase (MAO)
may be involved here. However, the observation that the
inhibitor of MAO activity, clorgyline, does not protect RLM
from oxidative stress (Fig. 3A, B) excludes this hypothesis. So
oxidation may be due to a still unknown mitochondrial amine
oxidase.
However, another mechanism may be proposed. Very recent
results obtained in our laboratory have shown that compounds
having secondary amino-groups form imino radicals by
interacting with Fe3+ ions of the iron–sulfur centers present in
respiratory complexes [32]. In turn, by interacting with
molecular oxygen, these radicals generate superoxide anion
and subsequently H2O2 and other ROS. A nitrogen present in the
guanidine group of agmatine (Nγ) may behave in precisely this
way, thus explaining the pro-oxidant effect of this amine [34].
Fig. 6. Redox state of mitochondrial sulfhydryl groups (A), glutathione (B) and
pyridine nucleotides (C) in presence of agmatine, Ca2+ and phosphate. RLM
were incubated for 20 min, as in experiment of Fig. 5. Agmatine concentrations
are indicated. Results of histograms A and B are mean values±SD of four
experiments. Statistical analysis on panels A and B was carried out with
Student's t-test (*p<0.05 vs. control). Panel C shows a typical experiment; four
others gave identical results.
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that glutathione peroxidase is operating, with the consequent
involvement of H2O2 and/or other ROS in inducing oxidative
stress. Oxidation of sulfhydryl groups (Fig. 3A), most probably
due to their interaction with oxidized glutathione [35] and/or
directly with ROS, accounts for the reduced phosphorylation
activity seen in the drop in the RCI and ADP/O ratio (Fig. 4).
This observation is in agreement with a previous paper showing
that superoxide anion or hydroxyl radicals inactivate the
F0F1ATP synthase complex [36]. The observation that NEM
and BHT maintain the values of RCI and ADP/O at normal
levels confirms the involvement of oxidative stress in inducing
mitochondrial alterations (results not reported). It is suggestedthat the oxidation of some sulfhydryl groups present in ATP-
synthase affect the activity of this enzyme.
Thiol oxidation also explains pore opening induced by Ca2+
alone (Fig. 5). In fact, as Fig. 6A shows, Ca2+ can cause the
oxidation of about 15% of thiols. This statement is supported by
a previous report demonstrating the involvement of critical thiol
groups in transition pore opening by Ca2+ [37], most probably
due to the membrane disorganization which follows the
interaction of the cation with membrane cardiolipins. This
may affect coenzyme Q mobility and favor the ROS production
[38] responsible for thiol oxidation. It should be emphasized
that these critical thiols belong to two cysteine residues located
on the adenine nucleotide translocase [37].
Oxidation of critical sulfhydryl groups, although with a
different mechanism of ROS production, is also involved in
amplification of the MPT seen when 10 and 100 μM agmatine
are incubated in the presence of Ca2+ (Fig. 5), when agmatine
behaves as a typical MPT amplifier. The observation that
pyridine nucleotides are not oxidized by low concentrations of
agmatine (Fig. 3C) seems to exclude the involvement of
glutathione reductase and the participation of these nucleotides
in oxidative stress. It should be noted that this amplification
provokes hyperproduction of superoxide anion and other ROS,
resulting in a redox catastrophe [39]. This fact is evidenced by
increased oxidation of thiols and glutathione (Fig. 6A, B;
compare with Fig. 3A, B) and oxidation of pyridine nucleotides
(Fig. 6C; compare with Fig. 3C).
Note that a particular behavior was observed with agmatine
at 1 mM concentration. In this condition, only a slight
increase in O2 uptake, when compared with the lower
concentration, was observed (Fig. 1A), most probably due to
electrophoretic transport of agmatine (here evidenced by the
ΔΨ drop shown in Fig. 1B) and higher production of H2O2.
Instead, the redox level of thiols, glutathione and pyridine
nucleotides (Fig. 3A–C) and phosphorylation parameters (Fig.
4) are not affected, and MPT is fully prevented (Fig. 5). The
inefficacy of oxidative effects may be due to the antioxidant
property that agmatine exhibits at higher concentrations (1–
2 mM), as also demonstrated for polyamines [33]. In these
conditions, the amine can produce ROS, as proposed above,
but the amount of still unreacted molecules may act as a
scavenger, thus exhibiting self-protection against the effects of
ROS produced by itself.
One proposal for the scavenging effect of agmatine is the
following. Agmatine reacts with hydroxyl radical to form
dihydroxyaminobutyl-guanidine; guanidobutyric aldehyde is
then formed by spontaneous dehydration and subsequent
hydrolysis. This property of agmatine would explain the
prevention of MPT, as agmatine can scavenge the ROS
responsible for pore opening and its amplification, respectively,
produced by Ca2+ and by itself. Note that the scavenging effect
demonstrated by polyamines is effective only against hydroxyl
radicals [33]. This fact leads to the conclusion that most of the
observed oxidative stress is due to this ROS. Indeed, it should
also be pointed out that the dose-dependent production of H2O2
(Fig. 2) most probably also reflects the parallel generation of
hydroxyl radicals which, however, are scavenged by unreacted
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and reactive at 10 and 100 μM.
In conclusion, these results demonstrate that, depending on
its exogenous concentration, agmatine can induce oxidative
stress on isolated mitochondria or, on the contrary, exhibit self-
protection. These effects have important consequences on
mitochondrial physio-pathology, as agmatine at low concentra-
tions combines a drop in energy transduction with the induction
or amplification of MPT. Instead, at high concentrations,
agmatine maintains the bioenergetic capacity of RLM at normal
level, without dissipating it with the opening of the pore. These
observations, obtained “in vitro”, give rise to speculations on the
possible effects of agmatine “in vivo”, as it may behave as a
regulator of cell energy content and trigger the apoptotic pathway.References
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